Richard J. Meelia
CEO @ Covidien
Richard J. Meelia is a startup investor at Covidien. Mr. Richard J. Meelia serves as the President of Mallinckrodt Inc. Mr. Meelia has been the Chief Executive Officer of Power Medical Interventions Inc., since September 2009. He served as the President of Infusaid, Inc. He served as the Chief Executive Officer and President of Tyco Healthcare at Kendall International Inc. Mr. Meelia served as theChief Executive Officer of Covidien Ltd. from January 2006 to July 1, 2011. He served as the President of Covidien Inc. from 1995 to July 1, 2011. He served as the Chief Executive Officer and President of Covidien Plc. He has been Chairman of Haemonetics Corp. since June 2011. He served as the Chairman of Covidien Plc from October 2008 to March 13, 2012. He served as Chief Executive Officer of tyco healthcare since June 2006 President of Tyco Healthcare and Specialty Product of Tyco International Ltd. since 1995. He served as Vice President of Tyco International Ltd. since June 2000. He serves as Chairman of the Board of Haeomonetics. He serves as Chairman of the Board of Apollo Endosurgery, Inc. and has been its Director since July 2012. He serves as a Director of Triangle, Inc. He serves as Associate of Kairos Partners L.P. He serves as a Director of Mallinckrodt Inc. He also serves on the Board of Governors of the Tufts-New England Medical Center and the Board of Trustees of St. Anselm College. He served as a Director of Aspect Medical Systems Inc. He served as a Director of VASAMED Inc. since June 1997 and Covidien plc since June 2007. He served as an Independent Director of Haemonetics Corp. He has a Bachelor's Degree from Saint Anselm College. Mr. Meelia earned an MBA degree from Boston College.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
About Covidien
Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments: Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry andmonitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products; Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM). The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups: - Endomechanical Instrumentsâ includes its laparoscopic instruments and surgical staplers. - Soft Tissue Repair Productsâ includes its sutures, mesh and biosurgery products. - Energy Devicesâ includes its vessel sealing, electrosurgical and ablation products and related capital equipment. Oximetry and Monitoring Productsâ includes its sensors, monitors and temperature management products. Airway and Ventilation Products—includes its airway, ventilator, breathing systems, sleep and inhalation therapy products. Vascular Devicesâ ”includes its compression and vascular therapy products. SharpSafety Productsâ includes its needles, syringes and sharps disposable products. Clinical Care Productsâ includes its urology, enteral feeding and other advanced woundcare products.
Covidien Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dennis Reilley
Member of the Board of Directors
|
|||
|
Frank Araya
Plant Manager
|
|||
|
James T. Frederick
Head of Human Resources
|
|||
Israel Kehat
Software Development Manager and Architect
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Richard J. Meelia?
Public channels for Richard J. Meelia include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
